Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
investing
14
×
life sciences
national blog main
san diego blog main
14
×
boston blog main
boston top stories
new york blog main
san diego top stories
fda
indiana blog main
national top stories
raleigh-durham blog main
san francisco blog main
seattle blog main
startups
boulder/denver blog main
boulder/denver top stories
deals
detroit blog main
detroit top stories
indiana top stories
national
new york top stories
raleigh-durham top stories
san francisco top stories
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer
cancer immunotherapy
clinical trials
pfizer
eli lilly
alzheimer's disease
bristol-myers squibb
merck
nonalcoholic steatohepatitis
What
roundup
bio
drug
cancer
companies
develop
new
ahead
alzheimer’s
amid
annual
asco
attention
biotech
bombast
business
caught
coronavirus
days
debate
device
discussion
disease
drugs
efforts
fda
growing
key
latest
life
meso’s
million
miss
pandemic
patients
pfizer’s
pharmaceutical
plan
presidential
prices
Language
unset
Current search:
investing
×
" san diego blog main "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
@xconomy.com
5 years ago
Boston Scientific Continues M&A Streak with $202M Deal for Cryterion
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More